Posts By: admin

https://www.dana-farber.org/newsroom/news-releases/2019/researchers-pinpoint-why-lymphoma-patients-may-become-resistant-to-specific-therapy–identify-strategy-to-overcome-it/

https://www.dana-farber.org/newsroom/news-releases/2019/researchers-devise-a-progression-risk-based-classification-for-patients-with-asymptomatic-waldenstr-m-macroglobulinemia/

https://www.dana-farber.org/newsroom/news-releases/2019/loss-of-a-dna-repair-system-creates-a-unique-vulnerability-in-many-cancer-types/

https://www.dana-farber.org/newsroom/news-releases/2019/combination-of-parp-inhibitor-and-targeted-therapy-significantly-outperforms-parp-inhibitor-alone-in-patients-with-chemotherapy-resistant-ovarian-cancer/

https://www.dana-farber.org/newsroom/news-releases/2019/drug-combination-may-become-new-standard-treatment-for-advanced-kidney-cancer/

https://www.dana-farber.org/newsroom/news-releases/2019/personalized-vaccine-to-be-tested-for-the-first-time-in-patients-with-kidney-cancer/

https://www.dana-farber.org/newsroom/news-releases/2018/her2-mutations-can-cause-treatment-resistance-in-metastatic-er-positive-breast-cancer/

https://www.dana-farber.org/newsroom/news-releases/2018/dana-farber-scientists-to-present-research-on-myeloma-progression-from-precursor-conditions-and-novel-approaches-to-treatment/

https://www.dana-farber.org/newsroom/news-releases/2018/venetoclax-combination-approved-for-elderly-aml/

https://www.dana-farber.org/newsroom/news-releases/2018/dana-farber-scientists-find-new-drug-targets-in-aggressive-cancers/

https://www.dana-farber.org/newsroom/news-releases/2018/study-resolves-decades-old-mystery-about-the-most-commonly-mutated-gene-in-cancer/

https://www.dana-farber.org/newsroom/news-releases/2018/fast-growing-organoid-models-of-ovarian-cancer-could-aid-rapid-drug-treatment-selection/

https://www.dana-farber.org/newsroom/news-releases/2018/study-findings-in-metastatic-hpv-linked-head-and-neck-cancer-may-help-guide-treatment/

https://www.dana-farber.org/newsroom/news-releases/2018/study-of-genomic-changes-in-multiple-myeloma-may-lead-to-new-approaches-to-treating-early–smoldering-myeloma/

https://www.dana-farber.org/newsroom/news-releases/2018/study-finds-melanoma-biomarkers-predicting-checkpoint-blocker-response/

https://www.dana-farber.org/newsroom/news-releases/2018/study-finds-inherited-gene-variants-in-10-percent-of-pancreatic-cancer-patients/

http://www.dana-farber.org/newsroom/news-releases/2018/real-time-dna-sequencing-in-advanced-pancreatic-cancer-can-guide-precision-medicine-treatment/

http://www.dana-farber.org/newsroom/news-releases/2018/expanded-lab-facility-at-dana-farber-aids-personalized-medicine-efforts/

http://www.dana-farber.org/newsroom/news-releases/2018/genomic-analysis-unravels-complexities-of-the-most-common-form-of-lymphoma-and-enables-personalized-treatment/

http://www.dana-farber.org/newsroom/news-releases/2018/in-multiple-myeloma–different-types-of-blood-biopsies-match-up-well-with-bone-marrow-tests/

http://www.dana-farber.org/newsroom/news-releases/2018/dual-kinase-inhibitor-shows-promise-in-multiple-cancer-types-in-phase-i-trial/

http://www.dana-farber.org/newsroom/news-releases/2018/comprehensive-map-of-altered-gene-pathways-in-dozens-of-cancer-types-will-guide-research-in-precision-cancer-medicine/

http://www.dana-farber.org/newsroom/news-releases/2018/small-genetic-script-causes-drug-resistance-in-some-ovarian-cancers/

http://www.dana-farber.org/newsroom/news-releases/2018/scientists-uncover-“long-tail”-of-nearly-100-genes-mutated-in-prostate-cancer/

http://www.dana-farber.org/newsroom/news-releases/2018/immunotherapy/parp-inhibitor-combination-produces-ovarian-cancer-remissions-at-much-higher-rate-than-either-drug-alone–phase-i/ii-clinical-trial-shows/

http://www.dana-farber.org/newsroom/news-releases/2018/dana-farber-s-bank-of-patient-derived-tumor-xenografts-gets-major-boost-from-novartis/

http://www.dana-farber.org/newsroom/news-releases/2018/study-identifies-predictors-of-immunotherapy-response-in-head-and-neck-cancer/

http://www.dana-farber.org/newsroom/news-releases/2018/study-sheds-new-light-on-mechanism-of-breast-cancer-treatment-resistance/

http://www.dana-farber.org/newsroom/news-releases/2017/dana-farber/brigham-and-women-s-cancer-center-launches-new-program-to-target-aggressive-thyroid-cancers/

http://www.dana-farber.org/newsroom/news-releases/2017/new-biomarker-predicts-metastatic-prostate-cancers/

http://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-08-22-studies-highlight-potential-new-targets-for-immunotherapy

https://www.eurekalert.org/pub_releases/2017-07/bawh-scb071017.php

http://www.usnews.com/news/articles/2015/11/04/wuxi-nextcode-to-sequence-genomes-of-1-000-cancer-patients

http://www.washingtonpost.com/national/health-science/looking-for-answers-in-cancers-exceptional-responders/2015/06/13/9cf0ec78-0571-11e5-a428-c984eb077d4e_story.html

http://www.dana-farber.org/Newsroom/News-Releases/new-chemical-technology-boosts-potency-of-targeted-cancer-therapy.aspx

http://www.dana-farber.org/newsroom/news-releases/2015/international-study-of-advanced-prostate-cancer-genome-finds-abundance-of-potential-targets-for-drug-therapy/

http://www.dana-farber.org/Newsroom/News-Releases/new-drug-combination-extends-survival-of-patients-with-metastatic-colorectal-cancer.aspx

http://www.dana-farber.org/Newsroom/News-Releases/New-targeted-drug-promising-treatment-option-in-resistant-EGFR-positive-lung-cancers.aspx

http://www.dana-farber.org/Newsroom/News-Releases/minor-gene-mutations-can-produce-extensive-disruption-of-protein-interactions-study-finds.aspx

http://www.dana-farber.org/Newsroom/News-Releases/olaparib-and-investigational-pi3k-inhibitor-bkm120-combination-active-against-ovarian-and-breast-cancer-subtypes.aspx

http://www.dana-farber.org/Newsroom/News-Releases/dana-farbers-dandrea-selected-to-lead-new-su2c-ovarian-cancer-dream-team.aspx

http://www.dana-farber.org/Newsroom/News-Releases/Unregulated-web-marketing-of-genetic-tests-for-personalized-cancer-care-raises-concerns-in-new-study.aspx

http://www.dana-farber.org/Newsroom/News-Releases/novel-precision-medicine-tool-could-help-personalize-cancer-treatments.aspx

http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-experts-share-five-things-you-should-know-about-precision-medicine.aspx

http://www.dana-farber.org/Newsroom/News-Releases/study-identifies-promising-drug-target-in-certain-breast-and-ovarian-cancers.aspx

http://www.dana-farber.org/Newsroom/News-Releases/large-study-catalogs-genetic-culprits-in-head-and-neck-cancers.aspx

http://www.dana-farber.org/Newsroom/News-Releases/combined-therapy-can-reduce-chance-of-recurrence-in-women-with-small-her-2-positive-breast-tumors.aspx